Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis
- 1 October 2002
- journal article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 10 (10) , 799-807
- https://doi.org/10.1053/joca.2002.0829
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- PATHWAYS BY WHICH INTERLEUKIN 17 INDUCES ARTICULAR CARTILAGE BREAKDOWN IN VITRO AND IN VIVOCytokine, 2001
- Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-κB and receptor activator of nuclear factor κB (RANK)/RANK ligand signaling?Bone, 2001
- Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokinesArthritis & Rheumatism, 2000
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- Interleukin-17-induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-activated Protein Kinases and NF-κBJournal of Biological Chemistry, 1998
- Macrophage Inflammatory Protein-Iβ: A C-C Chemokine in OsteoarthritisClinical Immunology and Immunopathology, 1995
- Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis.Annals of the Rheumatic Diseases, 1993
- Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugsArthritis & Rheumatism, 1991
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986